Poor Muscle Status, Dietary Protein Intake, Exercise Levels, Quality of Life and Physical Function in Women with Metastatic Breast Cancer at Chemotherapy Commencement and during Follow-Up
Authors:
Open Access
- 5 January 2023
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 30 (1) , 688-703
Abstract
This study aimed to investigate nutritional status, body composition, dietary protein intake, handgrip strength, 6 min or 4 m walk tests, self-reported physical activity, physical function, and quality of life (QoL-EORTC-QLQc30) at commencement of chemotherapy; to detect changes over time (from commencement of chemotherapy, and after 3, 6, 12, 26 and 52 weeks) in women with metastatic breast cancer (MBC); and to investigate the relationship between nutritional variables. ‘Sarcopenia’ was defined as low muscle mass and strength, ‘myosteatosis’ as muscle fat-infiltration (CT scan). Continuous variables were analysed using paired t-tests between baseline and follow-ups. Fifteen women (54y, 95% CI [46.3;61.2]) were recruited. At baseline, malnutrition was present in 3 (20%) participants, sarcopenia in 3 (20%) and myosteatosis in 7 (54%). Thirteen (87%) participants had low protein intake; low handgrip strength was observed in 0, and low walk test distance and physical activity in four (27%) participants. Physical function and QoL were low in 10 (67%) and 9 (60%), respectively. QoL between baseline and 52 weeks decreased by 11.7 (95% CI [2.4;20.9], p = 0.025). Other variables did not significantly change over time. In this small study sample, myosteatosis, low dietary protein intake, low exercise levels and impaired quality of life and physical function are common.Keywords
This publication has 54 references indexed in Scilit:
- Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancerLung Cancer, 2012
- Nutrition and physical activity guidelines for cancer survivorsCA: A Cancer Journal for Clinicians, 2012
- Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent GliomaJournal of Clinical Oncology, 2011
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine TreatmentClinical Cancer Research, 2009
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine careApplied Physiology, Nutrition, and Metabolism, 2008
- Muscle Strength, Body Composition, and Physical Activity in Women Receiving Chemotherapy for Breast CancerIntegrative Cancer Therapies, 2006
- Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapySupportive Care in Cancer, 2006
- Cancer-associated malnutritionEuropean Journal of Oncology Nursing, 2005
- Energy Balance in Women With Breast During Adjuvant TreatmentJournal of the American Dietetic Association, 1999
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993